Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysis

MeSH terms

• Hepacivirus / drug effects
• Hepatitis C / drug therapy*
• Hepatitis C / virology
• Humans
• Kidney Failure, Chronic / therapy
• Male
• Middle Aged
• Oligopeptides / blood*
• Oligopeptides / pharmacokinetics
• Oligopeptides / therapeutic use
• Protease Inhibitors / blood*
• Protease Inhibitors / pharmacokinetics
• Protease Inhibitors / therapeutic use
• Renal Dialysis*